Microeconomics
- All
- AI
- Markets
- Macroeconomics
As global markets navigate a mix of volatility and optimism, with U.S. stocks rebounding and central banks signaling further monetary easing, investors are increasingly focused on identifying opportunities amid the shifting economic landscape. In this env
Circular investments contributed to the dot-com crash.
Bitcoin’s volatility isn’t gone, and it could still fall by as much as half its value, according to Tom Lee, chairman of BitMine. Key Takeaways: BitMine chair Tom Lee warned that Bitcoin could still see 50% drawdowns, despite growing institutional adoptio
Sitting in Beijing’s reserve is control over an even more vital supply chain: medicine. China’s power rests on its grip over the global supply of active pharmaceutical ingredients, or APIs, which are core components of commercial drugs. Beijing’s broad
Models of investor positioning show computer-based and discretionary funds recently cut their stock exposure by the most since early April, when President Donald Trump’s tariff threats sent the S&P 500 Index teetering near a bear market. With euphoria ru
Automaker to lift investment and increase localisation in the US.
Wind farm developers are bracing for cuts to net zero funding as Ed Miliband comes under pressure to reduce energy bills.
Trump-world is borrowing a page from China command-and-control economy, in which the state has a stronger hand with direct shares in firms
With CPI data hours away, ChatGPT explains what could drive Bitcoin’s next move and how to trade it safely.
The Chancellor is reportedly planning to incorporate national insurance into the tax obligations for certain UK professionals.
UK car output was sharply down in September as UK’s largest vehicle maker suspended production after cyber-attack.
Ginkgo Bioworks Holdings has maintained its fair value price target at $12.00 per share, with only slight shifts in the underlying assessment from market analysts. The minor increase in the discount rate reflects a careful balancing of optimism about the
Core Laboratories (CLB) posted net profit margins of 6.2% in its most recent results, topping last year's 5%. Earnings have risen strongly over the past five years, with a 43.1% annualized growth rate. However, the most recent annual growth has slowed to
Amalgamated Financial (AMAL) reported a net profit margin of 33.9%, unchanged from the prior year, and posted annual earnings growth of 4.5%, compared to its five-year compound growth rate of 19.7%. With high quality past earnings, a Price-To-Earnings Rat